Medifast, Inc. (MED)
After hours:
| Previous close | 68.31 |
| Open | 67.75 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 800 |
| Day's range | 67.75 - 70.00 |
| 52-week range | 61.94 - 131.42 |
| Volume | |
| Avg. volume | 172,820 |
| Market cap | 759.65M |
| Beta (5Y monthly) | 1.25 |
| PE ratio (TTM) | 6.35 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 6.60 (9.46%) |
| Ex-dividend date | 18 Sept 2023 |
| 1y target est | N/A |
- Business Wire
Medifast Announces Third Quarter 2023 Financial Results
BALTIMORE, November 06, 2023--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the third quarter ended September 30, 2023.
- Business Wire
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2023
BALTIMORE, October 23, 2023--Medifast (NYSE: MED), the company behind the health and wellness community OPTAVIA®, will announce financial results for the third quarter ended September 30, 2023 on Monday, November 6, 2023, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
- PR Newswire
Medifast Named as One of the "Best Companies To Work For" by U.S. News & World Report
Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution OPTAVIA®, today announced that it has been recognized in the 2023-2024 rankings by U.S. News & World Report as one of the nation's "Best Companies to Work For" in the food and drink industry.
